MedTrace Logo

HF10 Treatment of Chronic Knee Pain

NCT04020211 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2020-11-12

No results posted yet for this study

Summary

This is a multi-center study where patients who meet the eligibility criteria will be treated with HF10 therapy for their chronic knee pain post-orthopedic surgery. The primary endpoint will be assessed at 3 months, but observational assessments will continue until study completion at 12 months following implant.

Conditions

  • Chronic Pain Post-Procedural

Interventions

DEVICE

Senza HF10 Therapy

Senza 10kHz Spinal Cord Stimulation

Sponsors & Collaborators

  • Nevro Corp

    lead INDUSTRY

Principal Investigators

  • David Caraway, MD · Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-14
Primary Completion
2019-12-12
Completion
2019-12-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04020211 on ClinicalTrials.gov